BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 23911970)

  • 1. Hormones and arterial stiffness in patients with chronic kidney disease.
    Gungor O; Kircelli F; Voroneanu L; Covic A; Ok E
    J Atheroscler Thromb; 2013; 20(9):698-707. PubMed ID: 23911970
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The hormonal response to exercise.
    Galbo H
    Diabetes Metab Rev; 1986; 1(4):385-408. PubMed ID: 2873006
    [No Abstract]   [Full Text] [Related]  

  • 3. The contribution of thyroid dysfunction on cardiovascular disease in patients with chronic kidney disease.
    Tatar E; Kircelli F; Ok E
    Atherosclerosis; 2013 Mar; 227(1):26-31. PubMed ID: 23206977
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Progression of arterial stiffness is associated with changes in bone mineral markers in advanced CKD.
    Krishnasamy R; Tan SJ; Hawley CM; Johnson DW; Stanton T; Lee K; Mudge DW; Campbell S; Elder GJ; Toussaint ND; Isbel NM
    BMC Nephrol; 2017 Sep; 18(1):281. PubMed ID: 28870151
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endocrine changes in the newborn period.
    Kovar I; Harvey D
    Clin Endocrinol Metab; 1981 Mar; 10(1):73-87. PubMed ID: 7014049
    [No Abstract]   [Full Text] [Related]  

  • 6. Large artery stiffening and remodeling are independently associated with all-cause mortality and cardiovascular events in chronic kidney disease.
    Karras A; Haymann JP; Bozec E; Metzger M; Jacquot C; Maruani G; Houillier P; Froissart M; Stengel B; Guardiola P; Laurent S; Boutouyrie P; Briet M;
    Hypertension; 2012 Dec; 60(6):1451-7. PubMed ID: 23090769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis of endocrine abnormalities in uremia.
    Emmanouel DS; Lindheimer MD; Katz AI
    Endocr Rev; 1980; 1(1):28-44. PubMed ID: 6785085
    [No Abstract]   [Full Text] [Related]  

  • 8. Association of serum adiponectin concentration with aortic arterial stiffness in chronic kidney disease: from the KNOW-CKD study.
    Kim CS; Bae EH; Ma SK; Park SK; Lee JY; Chung W; Lee K; Kim YH; Oh KH; Ahn C; Kim SW;
    Clin Exp Nephrol; 2017 Aug; 21(4):608-616. PubMed ID: 27514393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The most frequent hormonal disorders found in chronic hepatopathy].
    Cotrozzi G; Relli P; Amico A; Betti L; Lupi R
    Clin Ter; 1985 Jan; 112(2):101-19. PubMed ID: 2861931
    [No Abstract]   [Full Text] [Related]  

  • 10. Association between Ophthalmological Changes and Cardiovascular Diseases in Patients with Chronic Kidney Disease Undergoing Hemodialysis.
    Nokiba H; Takei T; Suto C; Nitta K
    J Atheroscler Thromb; 2015; 22(12):1248-54. PubMed ID: 26133318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormonal regulation of lipoprotein lipase activity].
    Piskorska D; Kopieczna-Grzebieniak E
    Przegl Lek; 1990; 47(11):760-2. PubMed ID: 2098844
    [No Abstract]   [Full Text] [Related]  

  • 12. Renal metabolism of peptide hormones.
    Rabkin R; Kitaji J
    Miner Electrolyte Metab; 1983; 9(4-6):212-26. PubMed ID: 6361510
    [No Abstract]   [Full Text] [Related]  

  • 13. Thyroid hormones associate with risk of incident chronic kidney disease and rapid decline in renal function: a prospective investigation.
    Huang X; Ding L; Peng K; Lin L; Wang T; Zhao Z; Xu Y; Lu J; Chen Y; Wang W; Bi Y; Ning G; Xu M
    J Transl Med; 2016 Dec; 14(1):336. PubMed ID: 27914474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arterial stiffness in chronic kidney disease: a modifiable cardiovascular risk factor?
    Pickup L; Radhakrishnan A; Townend JN; Ferro CJ
    Curr Opin Nephrol Hypertens; 2019 Nov; 28(6):527-536. PubMed ID: 31361609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormones in milk.
    Koldovský O; Thornburg W
    J Pediatr Gastroenterol Nutr; 1987; 6(2):172-96. PubMed ID: 3320320
    [No Abstract]   [Full Text] [Related]  

  • 16. Serum uric acid and arterial stiffness in hypertensive chronic kidney disease patients: sex-specific variations.
    Elsurer R; Afsar B
    Blood Press Monit; 2014 Oct; 19(5):271-9. PubMed ID: 24892881
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arterial stiffness in chronic kidney disease: an update.
    Taal MW
    Curr Opin Nephrol Hypertens; 2014 Mar; 23(2):169-73. PubMed ID: 24389732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Endocrine changes in hepatic cirrhosis].
    Greco AV; Ghirlanda G; Altomonte L; Manna R; Palumbo P; Modugno I; Bertoli A
    Recenti Prog Med; 1981 Sep; 71(3):235-53. PubMed ID: 7034080
    [No Abstract]   [Full Text] [Related]  

  • 19. Arterial stiffness and pulse pressure in CKD and ESRD.
    Briet M; Boutouyrie P; Laurent S; London GM
    Kidney Int; 2012 Aug; 82(4):388-400. PubMed ID: 22534962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Role of the morphogenetic proteins FGF-23 and Klotho and the glycoprotein sclerostin in the assessment of the risk of cardiovascular diseases and the prognosis of chronic kidney disease].
    Milovanova LY; Milovanov YS; Kudryavtseva DV; Markina MM; Milovanova SY; Kozlovskaya LV; Lebedeva MV; Beketov VD; Moiseev SV; Mukhin NA; Fomin VV; Svistunov AA
    Ter Arkh; 2015; 87(6):10-16. PubMed ID: 26281189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.